YOLFTbeta
Agape ATP Corporation Common Stock

Agape ATP Corporation Common Stock

ATPC · NASDAQ · Consumer Defensive / Packaged Foods

1.27USD-0.09 (-6.62%)

Price History

Full chart

Market Stats

Previous Close1.36
Open1.37
Day Range1.27 – 1.37
52-Week Range1.72 – 73.50
Volume6.40K
Market Cap2.24M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.96
Dividend Yield0.00%
Beta0.42
50-Day Avg2.46
200-Day Avg3.73

About

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. The company operates in two segments, Skin care, health and wellness; and Green energy. It offers two series of programs that consist of various services and products under the ATP Zeta Health Program and E.A.T.S. names. The company also provides ionized and high bioavailability nutrients to enhance absorption at the cellular level, energized mineral concentrate, soy protein isolate powder, LIVO5, and solutions for sustainability and energy savings; and promotes environmental stewardship. In addition, it promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. Further, the company provides renewable energy products, technical solutions, installations, and maintenance services, as well as digital wellness platform. Agape ATP Corporation was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEODr. Kok Choong How
  • Employees18
  • HeadquartersLot 1705 ? 1708, Faber Towers, Kuala Lumpur, Malaysia, 58100, USA
  • Websitehttps://www.atpc.com.my

Leadership

  • Dr. Kok Choong HowChairman of the Board, Founder, Group CEO, President, COO, Treasurer & Secretary · b. 1964
  • Mr. Kam Fan Lee CPAChief Financial Officer · b. 1962
  • Dr. Wilfrendo Fernando Cortizo Ph.D.Executive Director · b. 1957
  • Mr. Wan Lock TingVice President of Corporate Finance · b. 1993

Financials

Income Statement

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--487.00K1.55M858.72K3.45M1.02M1.86M1.43M1.32M1.52M
Growth (%)---+217.46%-44.46%+302.06%-70.55%+82.56%-22.92%-7.57%+15.23%
Cost of Revenue--441.41K1.44M766.96K775.86K297.33K666.04K494.52K563.60K706.18K
Gross Profit--45.60K109.35K91.77K2.68M719.63K1.19M936.57K759.15K818.08K
Gross Margin--9.36%7.07%10.69%77.53%70.76%64.13%65.44%57.39%53.67%
Operating Expense--412.56K623.87K624.54K2.83M2.58M2.72M3.08M3.33M4.07M
Operating Income-300.00K-75.36K-366.96K-514.51K-532.77K-158.13K-1.86M-1.53M-2.15M-2.57M-3.26M
Operating Margin---75.35%-33.28%-62.04%-4.58%-182.76%-82.59%-150.00%-194.55%-213.65%
EBITDA--75.36K-366.96K-514.51K-677.87K5.34K-2.17M-1.45M-1.88M-2.25M-2.08M
EBITDA Margin---75.35%-33.28%-78.94%0.15%-213.42%-78.22%-131.59%-170.44%-136.29%
Net Income-300.00K-75.36K-130.27K-519.64K-677.86K354.77K-2.52M-1.69M-2.10M-2.47M-2.28M
Net Income Margin---26.75%-33.61%-78.94%10.28%-248.21%-90.86%-146.88%-186.77%-149.57%

Balance Sheet

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets102.31M2.71M5.13M4.34M7.21M4.72M2.79M5.74M3.24M24.59M
Total Liabilities25.00K8.10K144.29K144.29K83.99K1.29M1.41M1.23M1.36M1.31M2.17M
Total Equity-24.99K2.30M2.56M2.56M4.25M5.92M3.31M1.54M4.37M1.93M22.46M
Cash102.31M1.86M1.86M238.94K3.52M622.50K1.44M4.83M2.04M140.07K
Total Debt-1003.92K-3.95K395.76K240.58K82.71K437.72K362.78K229.79K
Net Debt-10-2.31M-1.86M-1.86M-234.99K-3.12M-381.92K-1.36M-4.39M-1.68M89.71K

Cash Flow

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--100.26K-347.98K-347.98K-113.94K-557.95K-845.84K-811.68K-2.00M-2.73M-2.41M
Investing Cash Flow---1.36M-1.36M-1.50K1.28M-3.96K-32.12K-17.25K-50.05K-23.00M
Financing Cash Flow1202.41M2.93M2.93M-4.57K-22.09K-19.06K-234.47K5.40M-11.86K23.50M
Capital Expenditure00004.73K4.91K3.96K32.12K52.32K50.16K1.05K
Free Cash Flow--100.26K-347.98K-347.98K-113.94K-562.86K-849.80K-843.80K-2.05M-2.78M-2.41M
FCF to OCF-100.00%100.00%100.00%100.00%100.88%100.47%103.96%102.61%101.84%100.04%

Earnings

Report DateMar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 14, 2024Aug 14, 2024Nov 12, 2024Mar 31, 2025May 15, 2025Aug 13, 2025Nov 13, 2025Aug 14, 2026Nov 12, 2026
EPS Estimate--------------------------0.00--
EPS Actual0.00-0.02-0.01-0.01-0.010.000.020.00-0.02-0.03-0.03-0.05-0.05-0.11-0.06-0.19-0.11-0.10-0.09-0.26-0.01-0.01-0.13-0.20-0.07-0.01-0.010.09-
Surprise-----------------------------
Timing--------------------Pre-marketPre-marketPre-market------

Key Statistics & Ratios

Market Cap2.24M
Enterprise Value2.23M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.70
Price / Book0.10
EPS-0.96
Book Value22.04
Revenue (TTM)1.32M
Gross Profit (TTM)779.18K
EBITDA-3.09M
Profit Margin-86.27%
Operating Margin-4023.77%
Return on Equity-5.48%
Return on Assets-7.90%
Shares Outstanding1.00M
Shares Float433.30K
Beta0.42
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
10.90%
Insiders
2.04%
Retail / Other
87.06%

Top Institutional Holders

  • Jane Street Group LLC
    23.66K2.36%
  • UBS Group AG
    2.59K0.26%
  • Two Sigma Investments LLC
    00.00%
  • XTX Topco Ltd
    00.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    340.00%

Stock Splits

  • Feb 10, 20261:50
  • Aug 30, 20241:20